致力于开发新的杂交瘤克隆,分泌单克隆抗体,以广泛的人类蛋白质,最终目的是覆盖整个人类蛋白质组。
NeoBiotechnologiesAntibodies
LicensingaswellasdevelopingnewHybridomaClonessecretingmonoclonalantibodiestoawidevarietyofhumanproteinswithanultimategoaltocovertheentirehumanproteome.AntibodyproductsareavailableforvariousapplicationsthroughourOEM-partners.Presently,companyisholdingmorethan1,000hybridomas.